Prof. Dr. Johannes Levin

Johannes Levin is professor for Clinical Neurodegeneration at the Department of Neurology at LMU Munich and deputy site leader of clinical research at the German Center for Neurodegenerative Diseases (DZNE), site Munich.

He has been working in the field of neurodegeneration for 20 years focusing clinically on movement disorders and genetic forms of dementia. The principal research focus is the molecular pathogenesis of neurodegenerative diseases with emphasis on protein aggregation, biomarker development and therapy development targeting protein aggregation. His work has contributed to the definition of the natural history, environmental factors, and treatment of neurodegenerative diseases. Based on this background he joined MODAG GmbH as part-time CMO where he continues his academic work on the oligomer modulator anle138b/emrusolmin in an industry setting, where the compound is currently at early stages of clinical development.

Moreover, Johannes is principal investigator in several national and international cohort studies including the Dominantly Inherited Alzheimer’s Network (DIAN) and the Genetic Fronto-temporal dementia Initiative (GENFI).

Johannes Levin is Spokesperson of the CAS Research Group Tools for Transnational Neuropsychiatric Research.